Literature DB >> 18333266

Idiopathic fibrosing pancreatitis associated with ulcerative colitis.

E Nve1, D Ribé, J Navinés, M J Villanueva, G Franch, A Torrecilla, J Blay, J M Badia.   

Abstract

Idiopathic fibrosing pancreatitis has been associated with Sjögren's syndrome, primary biliary cirrhosis and primary sclerosing cholangitis. This condition frequently develops in childhood and youth, and has also been related to ulcerative colitis and pericholangitis. Pancreatic complications have been rarely described as systemic complications of ulcerative colitis. A 25-year-old man presented with epigastric pain and jaundice. Abdominal ultrasonography, computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP) revealed a diffuse enlargement of the pancreas, filiform distal stenosis of the common bile duct and intrahepatic bile ducts, and pancreatic duct dilatation. At operation, a rock-hard and nodular pancreas was noted. Cholecystectomy and Roux-en-Y hepaticojejunostomy, with an access loop, was successfully performed. Idiopathic fibrosing pancreatitis should be considered in young patients with obstructive jaundice, especially those affected with chronic inflammatory or autoimmune diseases. Glucocorticoid therapy would be the first-line treatment, although many patients require operation.

Entities:  

Year:  2006        PMID: 18333266      PMCID: PMC2131411          DOI: 10.1080/13651820600686998

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  11 in total

Review 1.  [Autoimmune pancreatitis].

Authors:  I Nishimori; K Suda; I Oi; M Ogawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2000-11

Review 2.  Clinical aspects of autoimmune pancreatitis in Sjogren's syndrome.

Authors:  T Hayakawa; S Naruse; M Kitagawa; T Kondo
Journal:  JOP       Date:  2001-05

3.  Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?

Authors:  H SARLES; J C SARLES; R MURATORE; C GUIEN
Journal:  Am J Dig Dis       Date:  1961-07

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 5.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

6.  Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.

Authors:  F Seibold; P Weber; H Jenss; K H Wiedmann
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

7.  Pancreatic insufficiency associated with ulcerative colitis and pericholangitis.

Authors:  L E Gurian; E B Keeffe
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

8.  Idiopathic fibrosing pancreatitis: a cause of obstructive jaundice in childhood.

Authors:  G O Atkinson; J B Wyly; B B Gay; T I Ball; K J Winn
Journal:  Pediatr Radiol       Date:  1988

Review 9.  Idiopathic fibrosing pancreatitis causing obstructive jaundice in young adults: two case reports and literature review.

Authors:  J S Barkin; N Stollman; J Friedman; I Willis; E Robbins
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

10.  Obstructive jaundice in a patient with ulcerative colitis, Sjögren's syndrome and sarcoidosis.

Authors:  C D Johnson
Journal:  J R Soc Med       Date:  1989-06       Impact factor: 18.000

View more
  1 in total

1.  Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis.

Authors:  Shigeyuki Kawa; Kazuichi Okazaki; Kenji Notohara; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-11-16       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.